Genetic epidemiology of migraine and depression
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Background: Migraine and major depressive disorder (commonly referred to as depression) are both common disorders with a significant impact on society. Studies in both clinical and community-based settings have demonstrated a strong relationship between migraine and depression. In addition to complicating the diagnosis, depression that is comorbid with migraine may lower treatment adherence, increase risk of medication overuse and is associated with migraine chronification, thus leading to higher direct and indirect costs and poorer health-related outcomes with increased disability. Aim: The aim of this review is to summarise the current knowledge on the genetic epidemiology of migraine and depression and the possible biological mechanisms underlying their comorbidity. Methods: We present a narrative review reporting on the current literature. Results and conclusions: Epidemiological findings indicate that there is a bidirectional relationship between migraine and depression, with one disorder increasing the risk for the other and vice versa, suggesting shared biological mechanisms. Twin and family studies indicate that this bidirectional relationship can be explained, at least partly, by shared underlying genetically determined disease mechanisms. Although no genes have been robustly associated with the aetiology of both migraine and depression, genes from serotonergic, dopaminergic and GABAergic systems together with variants in the MTHFR and BDNF genes remain strong candidates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Classification of Headache Disorders, 3rd edition (beta version)
Headache Classification Committee of the International Headache Society (IHS) (2013) · Cephalalgia · doi:10.1177/0333102413485658 · Cited by 8,229
Power failure: why small sample size undermines the reliability of neuroscience
Button, K. S., Ioannidis, J. P. A., Mokrysz, C., Nosek, B. A., Flint, J., Robinson, E. S. J., & Munafò, M. R. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3475 · Cited by 7,641 · cited 1×
“The most likely reason for GWAS not supporting previously implicated candidate genes relates to the typically small sample sizes used in CGAS, which increase the chance of generating both false-positive and false-negative results (111).”
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
The NHGRI GWAS Catalog, a curated resource of SNP-trait associations
Welter, D., MacArthur, J., Morales, J., Burdett, T., Hall, P., Junkins, H., Klemm, A., Flicek, P., Manolio, T., Hindorff, L., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1229 · Cited by 2,707 · cited 1×
“GWAS have proven to be a powerful approach for detecting common variants associated with complex diseases (98).”
Cross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302
Kessler, R. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90026-g · Cited by 2,207 · cited 1×
“Like migraine, MDD is twice as common among females than males (10,11).”
A mega-analysis of genome-wide association studies for major depressive disorder
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke, S., Wray, N. R., Lewis, C. M., Hamilton, S. P., Weissman, M. M., Breen, G., Byrne, E. M., Blackwood, D. H. R., Boomsma, D. I., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.21 · Cited by 1,120
Self-citationDopamine neurons modulate neural encoding and expression of depression-related behaviour
Tye, K. M., Mirzabekov, J. J., Warden, M. R., Ferenczi, E. A., Tsai, H.-C., Finkelstein, J., Kim, S.-Y., Adhikari, A., Thompson, K. R., Andalman, A. S., et al. (2013) · Nature · doi:10.1038/nature11740 · Cited by 1,073 · cited 1×
“A growing body of evidence suggests that a dysfunctional dopaminergic system may be the mechanism underlying the symptoms of yawning and somnolence (‘sleepiness’) in migraine (53) and the lack of motivation and attention in depression (54).”
Andrade, L., Caraveo‐anduaga, J. J., Berglund, P., Bijl, R. V., Graaf, R. D., Vollebergh, W., Dragomirecka, E., Kohn, R., Keller, M., Kessler, R. C., et al. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.138 · Cited by 1,068 · cited 1×
“In addition, the different results observed for Caucasian and Asian CGAS samples may be complicated by the lower prevalence observed in Japan for both migraine (109) and depression (9); hence, larger studies in both Caucasian and Asian populations are required.”
Sparse whole-genome sequencing identifies two loci for major depressive disorder
CONVERGE consortium, Cai, N., Bigdeli, T. B., Kretzschmar, W., Li, Y., Liang, J., Song, L., Hu, J., Li, Q., Jin, W., et al. (2015) · Nature · doi:10.1038/nature14659 · Cited by 864 · cited 6×
“The utility of such is demonstrated by the use of female-only severe recurrent depression cases in the only successful MDD GWAS (104).”
InfluentialThe genetics of depression: A review
Levinson, D. F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.024 · Cited by 855 · cited 1×
“Also similarly to migraine, the extent of the genetic component in MDD is estimated to be approximately 40–50% based on twin studies (14).”
Comorbidity of migraine and depression: Investigating potential etiology and prognosis
Breslau, N., Lipton, R. B., Stewart, W. F., Schultz, L. R., & Welch, K. M. A. (2003) · Neurology · doi:10.1212/01.wnl.0000058907.41080.54 · Cited by 640
McWilliams, L. A., Goodwin, R. D., & Cox, B. J. (2004) · Pain · doi:10.1016/j.pain.2004.06.002 · Cited by 562 · cited 1×
“For instance, some studies (15,17) reported that migraine sufferers were two- to three-times more susceptible to suffering from depression than their healthy counterparts, and the prevalence of MDD in migraineurs was significantly higher than in non-migraineurs, especially for migraineurs aged 18–38 years (16).”
Belmaker, R. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035354 · Cited by 473
Headache and major depression: Is the association specific to migraine?
Breslau, N., Schultz, L. R., Stewart, W. F., Lipton, R. B., Lucia, V. C., & Welch, K. M. A. (2000) · Neurology · doi:10.1212/wnl.54.2.308 · Cited by 465
Genome-wide meta-analysis identifies new susceptibility loci for migraine
North American Brain Expression Consortium, Anttila, V., UK Brain Expression Consortium, the International Headache Genetics Consortium, Winsvold, B. S., Gormley, P., Kurth, T., Bettella, F., McMahon, G., Kallela, M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2676 · Cited by 410 · cited 2×
“zip) and the 2013 International Headache Genetics Consortium (IHGC) migraine GWAS (101).”
Gardner, A., & Boles, R. G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.030 · Cited by 333 · cited 1×
“Although this is the first time that a mitochondrial gene has been implicated in depression, the dysfunction of this organelle as a key factor in the onset of depression was previously hypothesised by the same authors and others (105).”
Zill, P., Baghai, T. C., Zwanzger, P., Schüle, C., Eser, D., Rupprecht, R., Möller, H.-J., Bondy, B., & Ackenheil, M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001525 · Cited by 323 · cited 2×
“(50) performed the first analysis of TPH2 in MDD.”
Haeffel, G. J., Getchell, M., Koposov, R. A., Yrigollen, C. M., De Young, C. G., Klinteberg, B. A., Oreland, L., Ruchkin, V. V., & Grigorenko, E. L. (2008) · Psychological Science · doi:10.1111/j.1467-9280.2008.02047.x · Cited by 96
Colle, R., Gressier, F., Verstuyft, C., Deflesselle, E., Lépine, J.-P., Ferreri, F., Hardy, P., Guilloux, J.-P., Petit, A.-C., Fève, B., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.013 · Cited by 55 · cited 1×
“It has been suggested that Met allele carriers secrete less BDNF protein than their counterparts, and that, among others outcomes, they might have an increased risk of suffering from depression (97).”
van Winkel, M., Peeters, F., van Winkel, R., Kenis, G., Collip, D., Geschwind, N., Jacobs, N., Derom, C., Thiery, E., van Os, J., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.02.005 · Cited by 41 · cited 1×
“The rs2049046 SNP has also been associated with antidepressant efficacy in depressed patients (96).”
Migraine genetics: current findings and future lines of research
Persico, A. M., Verdecchia, M., Pinzone, V., & Guidetti, V. (2015) · neurogenetics · doi:10.1007/s10048-014-0433-x · Cited by 25 · cited 1×
“To date, six GWAS have been completed in migraine and are reviewed in detail elsewhere in this issue (99).”
Cited by
Steffen, A., Nübel, J., Jacobi, F., Bätzing, J., & Holstiege, J. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02546-8 · Cited by 212
Depression comorbidity in migraine
Amoozegar, F. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1326882 · Cited by 73
Pérez de la Mora, M., Borroto-Escuela, D. O., Crespo-Ramírez, M., Rejón-Orantes, J. D. C., Palacios-Lagunas, D. A., Martínez-Mata, M. K., Sánchez-Luna, D., Tesoro-Cruz, E., & Fuxe, K. (2022) · Cells · doi:10.3390/cells11111826 · Cited by 21
Metadata
- Authors
- Yang, Y., Ligthart, L., Terwindt, G. M., Boomsma, D. I., Rodriguez-Acevedo, A. J., & Nyholt, D. R.
- Venue
- Cephalalgia
- Publisher
- SAGE Publications
- Published
- 2016-03-09
- Volume
- 36
- Issue
- 7
- Pages
- 679-691
- ISSN
- 0333-1024 (ISSN-L)
- 1468-2982
- OpenAlex
- W2294188090
- Cited by
- 75
- References
- 22
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.